EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy and safety of risperidone and aripiprazole in reducing severity of irritability in children with autism spectrum disorder: A randomized controlled trial

Prateek Kumar Panda, Indar Kumar Sharawat, Diksha Gupta, Achanya Palayullakandi, Suthiraj Sopanam, Sarama Saha

Brain and Development · 2025

DOI: 10.1016/j.braindev.2025.104454 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Brain and Development, 2025. Verfasst von Prateek Kumar Panda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, Uttarakhand 249203, India. Hauptthemen laut MEDLINE: Risperidone, Aripiprazole, Autism Spectrum Disorder, Irritable Mood. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: All-India Institute of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RisperidoneAripiprazoleAutism Spectrum DisorderIrritable MoodAntipsychotic AgentsHumansChildMaleFemaleAdolescentTreatment OutcomeSeverity of Illness Index

Stichwörter der Autor:innen

ASDAripiprazoleAutismChildrenCommunicationDevelopmental disorderIrritabilityRisperidone

Substanzen

RisperidoneAripiprazoleAntipsychotic Agents

Autor:innen und Institutionen

  • Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, Uttarakhand 249203, India.
  • Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, Uttarakhand 249203, India. Electronic address: sherawatdrindar@gmail.com.
  • Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand 249203, India.

Förderung

  • All-India Institute of Medical Sciences

Zitieren

APA

Panda, P. K., Sharawat, I. K., Gupta, D., Palayullakandi, A., Sopanam, S., & Saha, S. (2025). Efficacy and safety of risperidone and aripiprazole in reducing severity of irritability in children with autism spectrum disorder: A randomized controlled trial. Brain and Development. https://doi.org/10.1016/j.braindev.2025.104454

Vancouver

Panda PK, Sharawat IK, Gupta D, Palayullakandi A, Sopanam S, Saha S. Efficacy and safety of risperidone and aripiprazole in reducing severity of irritability in children with autism spectrum disorder: A randomized controlled trial. Brain and Development. 2025. doi:10.1016/j.braindev.2025.104454

BibTeX
@article{Panda2025,
  author = {Panda, Prateek Kumar and Sharawat, Indar Kumar and Gupta, Diksha and Palayullakandi, Achanya and Sopanam, Suthiraj and Saha, Sarama},
  title = {Efficacy and safety of risperidone and aripiprazole in reducing severity of irritability in children with autism spectrum disorder: A randomized controlled trial},
  journal = {Brain and Development},
  year = {2025},
  doi = {10.1016/j.braindev.2025.104454}
}
Kostenlos starten →